Jeanne Wei
Concepts (307)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Serum Response Factor | 9 | 2017 | 34 | 3.050 |
Why?
| Transcription Factors | 7 | 2017 | 640 | 2.060 |
Why?
| Myocardium | 13 | 2021 | 468 | 1.970 |
Why?
| Aging | 10 | 2016 | 776 | 1.580 |
Why?
| MicroRNAs | 4 | 2016 | 366 | 1.180 |
Why?
| Accidental Falls | 3 | 2022 | 116 | 1.160 |
Why?
| Heart | 6 | 2016 | 348 | 1.140 |
Why?
| Gene Expression Regulation | 12 | 2016 | 1146 | 1.110 |
Why?
| Mice | 16 | 2021 | 6403 | 0.930 |
Why?
| Glucose | 2 | 2017 | 353 | 0.930 |
Why?
| Heart Failure | 5 | 2019 | 550 | 0.870 |
Why?
| Physical Therapists | 1 | 2021 | 8 | 0.850 |
Why?
| Sirtuins | 1 | 2021 | 16 | 0.830 |
Why?
| Geriatrics | 4 | 2019 | 49 | 0.780 |
Why?
| Genetic Variation | 1 | 2021 | 262 | 0.730 |
Why?
| Primary Health Care | 2 | 2014 | 416 | 0.710 |
Why?
| Sirtuin 2 | 1 | 2017 | 11 | 0.670 |
Why?
| Actins | 2 | 2017 | 140 | 0.670 |
Why?
| RNA, Messenger | 7 | 2021 | 1276 | 0.660 |
Why?
| Doxorubicin | 5 | 2017 | 266 | 0.660 |
Why?
| Dementia | 2 | 2012 | 144 | 0.620 |
Why?
| Cytoskeletal Proteins | 1 | 2017 | 64 | 0.620 |
Why?
| Mitochondria, Heart | 1 | 2016 | 44 | 0.590 |
Why?
| Animals | 18 | 2021 | 14806 | 0.590 |
Why?
| Gastrostomy | 2 | 2014 | 60 | 0.580 |
Why?
| Metformin | 1 | 2015 | 69 | 0.540 |
Why?
| Aged | 24 | 2022 | 10476 | 0.540 |
Why?
| Alternative Splicing | 2 | 2021 | 62 | 0.520 |
Why?
| Oxygen Consumption | 1 | 2015 | 240 | 0.520 |
Why?
| Histones | 1 | 2016 | 338 | 0.500 |
Why?
| Hypoglycemic Agents | 1 | 2015 | 188 | 0.500 |
Why?
| beta-Galactosidase | 1 | 2013 | 42 | 0.490 |
Why?
| Physicians, Primary Care | 1 | 2014 | 50 | 0.490 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2013 | 83 | 0.470 |
Why?
| Hospitalization | 3 | 2018 | 675 | 0.470 |
Why?
| Humans | 41 | 2022 | 53051 | 0.460 |
Why?
| Endoscopy, Gastrointestinal | 1 | 2012 | 77 | 0.450 |
Why?
| Antibiotics, Antineoplastic | 3 | 2017 | 85 | 0.450 |
Why?
| Blood Glucose | 1 | 2015 | 514 | 0.450 |
Why?
| Health Services for the Aged | 1 | 2012 | 41 | 0.440 |
Why?
| Malnutrition | 1 | 2012 | 81 | 0.430 |
Why?
| Aged, 80 and over | 13 | 2021 | 3642 | 0.420 |
Why?
| Cardiomegaly | 1 | 2011 | 37 | 0.420 |
Why?
| Alzheimer Disease | 2 | 2016 | 327 | 0.410 |
Why?
| Nitric Oxide | 1 | 2013 | 293 | 0.410 |
Why?
| Patient Discharge | 2 | 2013 | 325 | 0.410 |
Why?
| Longevity | 2 | 2010 | 96 | 0.400 |
Why?
| Oxidative Stress | 2 | 2016 | 967 | 0.400 |
Why?
| Cell Line | 5 | 2017 | 1226 | 0.390 |
Why?
| Gene Expression Profiling | 2 | 2012 | 1119 | 0.390 |
Why?
| Education, Medical, Graduate | 1 | 2012 | 223 | 0.370 |
Why?
| Collagen | 1 | 2010 | 234 | 0.360 |
Why?
| Amino Acid Sequence | 5 | 2011 | 808 | 0.360 |
Why?
| Chronic Disease | 1 | 2012 | 630 | 0.360 |
Why?
| Endocarditis, Bacterial | 1 | 2009 | 39 | 0.360 |
Why?
| Amino Acids, Essential | 2 | 2021 | 123 | 0.350 |
Why?
| NADH Dehydrogenase | 1 | 2008 | 10 | 0.340 |
Why?
| Anabolic Agents | 2 | 2019 | 35 | 0.340 |
Why?
| Electron Transport Complex I | 1 | 2008 | 31 | 0.340 |
Why?
| Protein Structure, Tertiary | 2 | 2021 | 303 | 0.320 |
Why?
| Mice, Transgenic | 4 | 2014 | 729 | 0.320 |
Why?
| Ventricular Pressure | 1 | 2006 | 19 | 0.320 |
Why?
| Promoter Regions, Genetic | 4 | 2017 | 562 | 0.320 |
Why?
| Isoproterenol | 1 | 2006 | 65 | 0.310 |
Why?
| Insulin-Like Growth Factor I | 3 | 2016 | 149 | 0.310 |
Why?
| Female | 24 | 2021 | 28985 | 0.300 |
Why?
| Drug Therapy | 1 | 2006 | 51 | 0.300 |
Why?
| Trans-Activators | 3 | 2016 | 162 | 0.300 |
Why?
| Nutritional Physiological Phenomena | 1 | 2006 | 23 | 0.300 |
Why?
| Cachexia | 1 | 2006 | 26 | 0.290 |
Why?
| Protein Isoforms | 2 | 2021 | 139 | 0.280 |
Why?
| Nuclear Proteins | 3 | 2016 | 273 | 0.280 |
Why?
| Residence Characteristics | 1 | 2006 | 167 | 0.270 |
Why?
| Self Care | 1 | 2006 | 143 | 0.270 |
Why?
| Breast Neoplasms | 4 | 2017 | 1274 | 0.270 |
Why?
| Mitochondria | 3 | 2021 | 475 | 0.270 |
Why?
| Molecular Sequence Data | 4 | 2008 | 1037 | 0.260 |
Why?
| Independent Living | 2 | 2021 | 48 | 0.260 |
Why?
| Cells, Cultured | 4 | 2015 | 1840 | 0.260 |
Why?
| Human Umbilical Vein Endothelial Cells | 2 | 2016 | 100 | 0.260 |
Why?
| Cognition Disorders | 1 | 2006 | 249 | 0.260 |
Why?
| Human Growth Hormone | 2 | 2017 | 57 | 0.250 |
Why?
| Male | 17 | 2021 | 28342 | 0.250 |
Why?
| Cell Size | 2 | 2014 | 48 | 0.240 |
Why?
| Estrogens, Conjugated (USP) | 1 | 2002 | 3 | 0.240 |
Why?
| Proteins | 1 | 2006 | 406 | 0.230 |
Why?
| NIH 3T3 Cells | 3 | 2008 | 58 | 0.230 |
Why?
| Rats | 4 | 2017 | 3596 | 0.230 |
Why?
| Mice, Inbred C57BL | 4 | 2016 | 2064 | 0.230 |
Why?
| Base Sequence | 2 | 2017 | 756 | 0.220 |
Why?
| Cues | 1 | 2021 | 57 | 0.220 |
Why?
| Genome | 2 | 2021 | 71 | 0.220 |
Why?
| Cardiovascular Diseases | 2 | 2021 | 484 | 0.210 |
Why?
| Age Factors | 5 | 2010 | 1267 | 0.210 |
Why?
| Genetic Loci | 1 | 2021 | 64 | 0.200 |
Why?
| Exons | 1 | 2021 | 108 | 0.200 |
Why?
| Up-Regulation | 2 | 2014 | 538 | 0.200 |
Why?
| Zinc | 1 | 2021 | 58 | 0.200 |
Why?
| Focus Groups | 1 | 2021 | 209 | 0.200 |
Why?
| Animals, Newborn | 2 | 2014 | 400 | 0.200 |
Why?
| United States | 5 | 2019 | 5102 | 0.190 |
Why?
| Food, Formulated | 1 | 2019 | 47 | 0.190 |
Why?
| Ventricular Function, Left | 2 | 2017 | 179 | 0.180 |
Why?
| Conserved Sequence | 2 | 2011 | 59 | 0.180 |
Why?
| Blood | 1 | 2017 | 29 | 0.170 |
Why?
| Culture Media | 1 | 2017 | 103 | 0.170 |
Why?
| Chemokines | 1 | 2017 | 97 | 0.160 |
Why?
| Transcriptome | 2 | 2017 | 344 | 0.160 |
Why?
| Tissue Distribution | 3 | 2008 | 186 | 0.160 |
Why?
| Stroke Volume | 1 | 2017 | 140 | 0.160 |
Why?
| Neocortex | 1 | 2016 | 9 | 0.160 |
Why?
| Cerebrovascular Disorders | 2 | 2018 | 61 | 0.160 |
Why?
| Down Syndrome | 1 | 2018 | 106 | 0.150 |
Why?
| Homeostasis | 1 | 2017 | 238 | 0.150 |
Why?
| Dietary Proteins | 1 | 2019 | 252 | 0.150 |
Why?
| Cell Culture Techniques | 1 | 2017 | 122 | 0.150 |
Why?
| Biomedical Research | 1 | 2019 | 245 | 0.150 |
Why?
| Comorbidity | 2 | 2012 | 700 | 0.150 |
Why?
| Transfection | 1 | 2017 | 436 | 0.150 |
Why?
| cdc42 GTP-Binding Protein | 1 | 2015 | 12 | 0.140 |
Why?
| AMP-Activated Protein Kinases | 1 | 2015 | 32 | 0.140 |
Why?
| Blotting, Western | 3 | 2006 | 721 | 0.140 |
Why?
| Aorta | 1 | 2016 | 183 | 0.140 |
Why?
| Prodromal Symptoms | 1 | 2014 | 16 | 0.140 |
Why?
| Actin Cytoskeleton | 1 | 2014 | 27 | 0.130 |
Why?
| Enzyme Activation | 1 | 2015 | 346 | 0.130 |
Why?
| Gastroscopy | 1 | 2014 | 21 | 0.130 |
Why?
| Protein Kinases | 1 | 2015 | 95 | 0.130 |
Why?
| Cell Death | 1 | 2015 | 240 | 0.130 |
Why?
| Double-Blind Method | 4 | 2021 | 759 | 0.130 |
Why?
| Transcription, Genetic | 2 | 2016 | 465 | 0.130 |
Why?
| Hippocampus | 1 | 2016 | 244 | 0.130 |
Why?
| Protein Binding | 2 | 2008 | 787 | 0.130 |
Why?
| Hospital Mortality | 3 | 2018 | 471 | 0.130 |
Why?
| Down-Regulation | 2 | 2016 | 402 | 0.130 |
Why?
| Retrospective Studies | 4 | 2018 | 6079 | 0.120 |
Why?
| Coronary Disease | 1 | 2014 | 188 | 0.120 |
Why?
| Pneumonia, Aspiration | 1 | 2012 | 14 | 0.120 |
Why?
| Survival Analysis | 3 | 2013 | 799 | 0.120 |
Why?
| Eukaryotic Initiation Factors | 1 | 2012 | 5 | 0.120 |
Why?
| Argonaute Proteins | 1 | 2012 | 11 | 0.120 |
Why?
| Multigene Family | 1 | 2012 | 67 | 0.110 |
Why?
| Models, Biological | 2 | 2008 | 869 | 0.110 |
Why?
| Enteral Nutrition | 1 | 2012 | 134 | 0.110 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2013 | 118 | 0.110 |
Why?
| Adiponectin | 1 | 2012 | 76 | 0.110 |
Why?
| Deglutition Disorders | 1 | 2012 | 75 | 0.110 |
Why?
| Hypertension | 1 | 2016 | 558 | 0.110 |
Why?
| Endoplasmic Reticulum | 1 | 2012 | 122 | 0.110 |
Why?
| Forecasting | 1 | 2012 | 170 | 0.110 |
Why?
| Adipocytes | 1 | 2012 | 147 | 0.100 |
Why?
| Gene Expression | 3 | 2016 | 717 | 0.100 |
Why?
| Career Choice | 1 | 2012 | 121 | 0.100 |
Why?
| Length of Stay | 2 | 2018 | 706 | 0.100 |
Why?
| Adult | 6 | 2017 | 14383 | 0.100 |
Why?
| Signal Transduction | 2 | 2015 | 1850 | 0.100 |
Why?
| Mice, Inbred Strains | 1 | 2010 | 211 | 0.100 |
Why?
| Health Services Needs and Demand | 1 | 2012 | 200 | 0.100 |
Why?
| Algorithms | 1 | 2014 | 738 | 0.100 |
Why?
| Organ Size | 1 | 2010 | 263 | 0.100 |
Why?
| Heart Diseases | 1 | 2012 | 232 | 0.100 |
Why?
| Cell Nucleus | 1 | 2010 | 219 | 0.100 |
Why?
| Diagnosis, Differential | 1 | 2014 | 1185 | 0.090 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2013 | 307 | 0.090 |
Why?
| Time Factors | 4 | 2014 | 3439 | 0.090 |
Why?
| Longitudinal Studies | 2 | 2014 | 739 | 0.090 |
Why?
| Cardiovascular Agents | 1 | 2009 | 63 | 0.090 |
Why?
| Paclitaxel | 1 | 2009 | 101 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1572 | 0.090 |
Why?
| Curriculum | 1 | 2012 | 415 | 0.090 |
Why?
| Cardiology | 1 | 2010 | 99 | 0.090 |
Why?
| Cell Proliferation | 1 | 2013 | 1128 | 0.090 |
Why?
| Piperidines | 1 | 2009 | 103 | 0.090 |
Why?
| NAD | 1 | 2008 | 44 | 0.090 |
Why?
| Drug-Eluting Stents | 1 | 2009 | 114 | 0.090 |
Why?
| Pyrazoles | 1 | 2009 | 119 | 0.080 |
Why?
| Protein Subunits | 1 | 2008 | 87 | 0.080 |
Why?
| Serum Response Element | 1 | 2007 | 4 | 0.080 |
Why?
| Stereotyping | 1 | 2008 | 45 | 0.080 |
Why?
| Codon, Nonsense | 1 | 2007 | 26 | 0.080 |
Why?
| Health Status | 2 | 2009 | 389 | 0.080 |
Why?
| Placebos | 2 | 2009 | 98 | 0.080 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2009 | 172 | 0.080 |
Why?
| Inflammation | 1 | 2012 | 671 | 0.080 |
Why?
| HeLa Cells | 1 | 2008 | 304 | 0.080 |
Why?
| Reproducibility of Results | 2 | 2012 | 1334 | 0.080 |
Why?
| Models, Genetic | 1 | 2007 | 204 | 0.080 |
Why?
| Zinc Fingers | 1 | 2006 | 22 | 0.080 |
Why?
| Myocytes, Cardiac | 1 | 2008 | 148 | 0.080 |
Why?
| Sequence Alignment | 1 | 2006 | 156 | 0.070 |
Why?
| Organ Specificity | 1 | 2006 | 128 | 0.070 |
Why?
| Science | 1 | 2005 | 16 | 0.070 |
Why?
| Logistic Models | 1 | 2009 | 1032 | 0.070 |
Why?
| Heart Rate | 1 | 2008 | 369 | 0.070 |
Why?
| Dietary Supplements | 2 | 2021 | 451 | 0.070 |
Why?
| Stress, Psychological | 1 | 2008 | 288 | 0.070 |
Why?
| Treatment Outcome | 4 | 2018 | 5646 | 0.070 |
Why?
| Two-Hybrid System Techniques | 1 | 2004 | 26 | 0.070 |
Why?
| Atrial Natriuretic Factor | 1 | 2004 | 27 | 0.070 |
Why?
| Binding Sites | 1 | 2006 | 471 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 716 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2009 | 328 | 0.070 |
Why?
| Blotting, Northern | 1 | 2004 | 120 | 0.070 |
Why?
| Immunoprecipitation | 1 | 2004 | 76 | 0.070 |
Why?
| Blood Pressure | 1 | 2008 | 600 | 0.070 |
Why?
| Middle Aged | 7 | 2017 | 13685 | 0.070 |
Why?
| DNA, Complementary | 1 | 2004 | 151 | 0.070 |
Why?
| Sequence Homology, Amino Acid | 1 | 2004 | 193 | 0.070 |
Why?
| Patient Compliance | 1 | 2006 | 271 | 0.070 |
Why?
| Proportional Hazards Models | 3 | 2014 | 464 | 0.070 |
Why?
| Homeodomain Proteins | 1 | 2004 | 83 | 0.070 |
Why?
| Transcriptional Activation | 1 | 2004 | 146 | 0.060 |
Why?
| Plasmids | 1 | 2004 | 182 | 0.060 |
Why?
| Leukocytes, Mononuclear | 2 | 2016 | 140 | 0.060 |
Why?
| Glutathione Transferase | 1 | 2004 | 164 | 0.060 |
Why?
| Antineoplastic Agents | 1 | 2012 | 1290 | 0.060 |
Why?
| Microscopy, Fluorescence | 1 | 2004 | 203 | 0.060 |
Why?
| Cardiomyopathies | 1 | 2004 | 118 | 0.060 |
Why?
| Echocardiography, Doppler | 1 | 2003 | 61 | 0.060 |
Why?
| Models, Animal | 1 | 2003 | 267 | 0.060 |
Why?
| Ventricular Dysfunction, Left | 1 | 2003 | 104 | 0.060 |
Why?
| African Americans | 1 | 2008 | 717 | 0.060 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 157 | 0.060 |
Why?
| Aggression | 1 | 2002 | 65 | 0.060 |
Why?
| Point Mutation | 1 | 2002 | 80 | 0.060 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2003 | 130 | 0.060 |
Why?
| Drug Administration Schedule | 1 | 2002 | 428 | 0.050 |
Why?
| Cross-Sectional Studies | 1 | 2006 | 1584 | 0.050 |
Why?
| Psychiatric Status Rating Scales | 1 | 2002 | 361 | 0.050 |
Why?
| Risk Factors | 3 | 2018 | 4007 | 0.050 |
Why?
| DNA, Mitochondrial | 1 | 2002 | 128 | 0.050 |
Why?
| Geriatric Assessment | 1 | 2021 | 135 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2006 | 1700 | 0.050 |
Why?
| Qualitative Research | 1 | 2021 | 318 | 0.050 |
Why?
| National Institute on Aging (U.S.) | 1 | 2019 | 2 | 0.050 |
Why?
| Europe | 1 | 2019 | 106 | 0.050 |
Why?
| Beverages | 1 | 2019 | 83 | 0.040 |
Why?
| Meals | 1 | 2019 | 65 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2002 | 1119 | 0.040 |
Why?
| Registries | 2 | 2013 | 553 | 0.040 |
Why?
| Matrix Metalloproteinases | 1 | 2017 | 56 | 0.040 |
Why?
| Myocardial Infarction | 2 | 2014 | 468 | 0.040 |
Why?
| Lung Neoplasms | 1 | 2003 | 599 | 0.040 |
Why?
| Lysine | 1 | 2017 | 98 | 0.040 |
Why?
| Blood-Brain Barrier | 1 | 2016 | 66 | 0.040 |
Why?
| Polymorphism, Genetic | 1 | 2017 | 209 | 0.040 |
Why?
| Gene Regulatory Networks | 1 | 2017 | 124 | 0.040 |
Why?
| Arginine | 1 | 2017 | 188 | 0.040 |
Why?
| Angiotensin II | 1 | 2016 | 178 | 0.030 |
Why?
| Myocardial Revascularization | 1 | 2014 | 23 | 0.030 |
Why?
| Pilot Projects | 1 | 2017 | 808 | 0.030 |
Why?
| Analysis of Variance | 1 | 2016 | 676 | 0.030 |
Why?
| Intubation, Gastrointestinal | 1 | 2014 | 30 | 0.030 |
Why?
| Health Surveys | 1 | 2014 | 256 | 0.030 |
Why?
| Mice, Knockout | 1 | 2016 | 1006 | 0.030 |
Why?
| Acute Disease | 1 | 2014 | 419 | 0.030 |
Why?
| Cohort Studies | 1 | 2018 | 1541 | 0.030 |
Why?
| Molecular Sequence Annotation | 1 | 2012 | 32 | 0.030 |
Why?
| Lymphopenia | 1 | 2012 | 20 | 0.030 |
Why?
| Thapsigargin | 1 | 2012 | 10 | 0.030 |
Why?
| Tunicamycin | 1 | 2012 | 19 | 0.030 |
Why?
| Palmitic Acid | 1 | 2012 | 27 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2014 | 638 | 0.030 |
Why?
| Thrombocytopenia | 1 | 2012 | 95 | 0.030 |
Why?
| Sex Factors | 1 | 2014 | 817 | 0.030 |
Why?
| Cognition | 1 | 2014 | 354 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2014 | 1067 | 0.030 |
Why?
| RNA | 1 | 2012 | 182 | 0.030 |
Why?
| Stents | 1 | 2014 | 386 | 0.030 |
Why?
| Stem Cells | 1 | 2012 | 194 | 0.030 |
Why?
| Phosphorylation | 1 | 2012 | 645 | 0.020 |
Why?
| Survival Rate | 1 | 2013 | 1016 | 0.020 |
Why?
| Brazil | 1 | 2010 | 37 | 0.020 |
Why?
| Liver | 1 | 2016 | 1263 | 0.020 |
Why?
| Multicenter Studies as Topic | 1 | 2009 | 87 | 0.020 |
Why?
| Body Mass Index | 1 | 2012 | 718 | 0.020 |
Why?
| Safety | 1 | 2009 | 103 | 0.020 |
Why?
| Perceptual Masking | 1 | 2008 | 11 | 0.020 |
Why?
| Vocabulary | 1 | 2008 | 17 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 537 | 0.020 |
Why?
| Administration, Oral | 1 | 2009 | 481 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2009 | 309 | 0.020 |
Why?
| Patient Selection | 1 | 2009 | 300 | 0.020 |
Why?
| Attitude | 1 | 2008 | 90 | 0.020 |
Why?
| Body Composition | 1 | 2009 | 354 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2009 | 548 | 0.020 |
Why?
| Young Adult | 1 | 2016 | 4310 | 0.020 |
Why?
| Thrombosis | 1 | 2009 | 267 | 0.020 |
Why?
| Genetic Engineering | 1 | 2005 | 30 | 0.020 |
Why?
| Research | 1 | 2005 | 118 | 0.020 |
Why?
| Health Policy | 1 | 2005 | 172 | 0.020 |
Why?
| Adolescent | 1 | 2016 | 6889 | 0.020 |
Why?
| Risk Assessment | 1 | 2009 | 1419 | 0.020 |
Why?
| Cheek | 1 | 2002 | 9 | 0.010 |
Why?
| Mouth Mucosa | 1 | 2002 | 31 | 0.010 |
Why?
| Mitosis | 1 | 2002 | 110 | 0.010 |
Why?
| Cell Division | 1 | 2002 | 370 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2002 | 287 | 0.010 |
Why?
| Gene Deletion | 1 | 2002 | 292 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 2002 | 554 | 0.010 |
Why?
| Epithelial Cells | 1 | 2002 | 298 | 0.010 |
Why?
| Prognosis | 1 | 2003 | 2105 | 0.010 |
Why?
| Mutation | 1 | 2002 | 1432 | 0.010 |
Why?
| Infant | 1 | 2002 | 3699 | 0.010 |
Why?
| Child, Preschool | 1 | 2002 | 4146 | 0.010 |
Why?
| Neoplasms | 1 | 2002 | 1262 | 0.010 |
Why?
| Child | 1 | 2002 | 6942 | 0.010 |
Why?
|
|
Wei's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|